Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
13.53
-0.01 (-0.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neogenomics Inc
< Previous
1
2
3
4
5
6
Next >
Expert Ratings For NeoGenomics
September 24, 2024
Via
Benzinga
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
August 04, 2024
Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!
Via
Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024
July 29, 2024
NEO stock results show that NeoGenomics beat on revenue for the second quarter of 2024.
Via
InvestorPlace
NeoGenomics Earnings Analysis: Q1 Recap
May 10, 2024
Via
Benzinga
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
July 30, 2024
Via
Benzinga
Where NeoGenomics Stands With Analysts
April 30, 2024
Via
Benzinga
NEO Stock Earnings: NeoGenomics Beats EPS, Beats Revenue for Q1 2024
April 30, 2024
NEO stock results show that NeoGenomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
What 6 Analyst Ratings Have To Say About NeoGenomics
March 18, 2024
Via
Benzinga
Earnings Scheduled For March 15, 2024
March 15, 2024
Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million.
Via
Benzinga
Evaluating NeoGenomics: Insights From 4 Financial Analysts
February 21, 2024
Via
Benzinga
Goldman Sachs Maintains Buy Rating for NeoGenomics: Here's What You Need To Know
February 22, 2024
Via
Benzinga
NeoGenomics Stock Surged But Technicals Point To A Pullback
February 22, 2024
NeoGenomics stock price popped sharply this week after the company published strong financial results. It soared to a high of $16.50, its highest point since December 29th. It has soared by more than...
Via
Talk Markets
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...
Via
Benzinga
Recap: NeoGenomics Q4 Earnings
February 20, 2024
Via
Benzinga
NeoGenomics's Earnings Outlook
February 19, 2024
Via
Benzinga
Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?
February 21, 2024
NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an...
Via
Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
February 21, 2024
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
February 21, 2024
Shares of NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 21, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
January 17, 2024
The company must pay $57 million in damages, but that's far less than expected.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Earnings Scheduled For February 20, 2024
February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Via
Benzinga
Bull of the Day - NeoGenomics
January 12, 2024
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
Via
Benzinga
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
December 28, 2023
Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from
Via
Benzinga
Stocks Edge Higher As End Of 2023 Approaches
December 28, 2023
The SPX is less than 10 points away from record close territory, and with one day left, all three major indexes are heading toward sizable December wins.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.